These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39201075)

  • 21. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.
    McDonnell MJ; Aliberti S; Goeminne PC; Restrepo MI; Finch S; Pesci A; Dupont LJ; Fardon TC; Wilson R; Loebinger MR; Skrbic D; Obradovic D; De Soyza A; Ward C; Laffey JG; Rutherford RM; Chalmers JD
    Lancet Respir Med; 2016 Dec; 4(12):969-979. PubMed ID: 27864036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics, radiological features, and disease severity of bronchiectasis according to the spirometric pattern.
    Kim SH; Yang B; Yoo JY; Cho JY; Kang H; Shin YM; Kim EG; Lee KM; Choe KH
    Sci Rep; 2022 Aug; 12(1):13167. PubMed ID: 35915114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Fractional Exhaled Nitric Oxide in Diagnosing Asthmatic Type 2 Chronic Rhinosinusitis With Nasal Polyps.
    Park JA; Cha H; Yang SK; Ryu HT; Kim DW; Hong SN; Yang MS; Kim DW
    Am J Rhinol Allergy; 2023 Sep; 37(5):524-530. PubMed ID: 37160729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of two prognostic scores (BSI and FACED) in a Spanish cohort of adult patients with bronchiectasis and improvement of the FACED predictive capacity for exacerbations.
    Rosales-Mayor E; Polverino E; Raguer L; Alcaraz V; Gabarrus A; Ranzani O; Menendez R; Torres A
    PLoS One; 2017; 12(4):e0175171. PubMed ID: 28384311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts.
    McDonnell MJ; Aliberti S; Goeminne PC; Dimakou K; Zucchetti SC; Davidson J; Ward C; Laffey JG; Finch S; Pesci A; Dupont LJ; Fardon TC; Skrbic D; Obradovic D; Cowman S; Loebinger MR; Rutherford RM; De Soyza A; Chalmers JD
    Thorax; 2016 Dec; 71(12):1110-1118. PubMed ID: 27516225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Which scoring system is better in association with exercise capacity and health status in noncystic fibrosis bronchiectasis patients?
    Varol Y; Doğan Şahin H; Aksel N; Çırak AK
    Turk J Med Sci; 2021 Apr; 51(2):631-637. PubMed ID: 33081435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics and validation of bronchiectasis severity score systems for post-tuberculosis bronchiectasis.
    Wang H; Ji XB; Li CW; Lu HW; Mao B; Liang S; Cheng KB; Bai JW; Martinez-Garcia MA; Xu JF
    Clin Respir J; 2018 Aug; 12(8):2346-2353. PubMed ID: 29790656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sputum neutrophil elastase and its relation to pediatric bronchiectasis severity: A cross-sectional study.
    Ali HA; Fouda EM; Salem MA; Abdelwahad MA; Radwan HH
    Health Sci Rep; 2022 May; 5(3):e581. PubMed ID: 35509417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fractional Exhaled Nitric Oxide is Associated with the Severity of Stable COPD.
    Liu X; Zhang H; Wang Y; Lu Y; Gao Y; Lu Y; Zheng C; Yin D; Wang S; Huang K
    COPD; 2020 Apr; 17(2):121-127. PubMed ID: 32116037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis.
    Busse WW; Wenzel SE; Casale TB; FitzGerald JM; Rice MS; Daizadeh N; Deniz Y; Patel N; Harel S; Rowe PJ; Graham NMH; O'Riordan T; Pavord ID
    Lancet Respir Med; 2021 Oct; 9(10):1165-1173. PubMed ID: 34181876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study.
    Choate R; Aksamit TR; Mannino D; Addrizzo-Harris D; Barker A; Basavaraj A; Daley CL; Daniels MLA; Eden E; DiMango A; Fennelly K; Griffith DE; Johnson MM; Knowles MR; McShane PJ; Metersky ML; Noone PG; O'Donnell AE; Olivier KN; Salathe MA; Schmid A; Thomashow B; Tino G; Winthrop KL; Stone G
    Respir Med; 2021 Feb; 177():106285. PubMed ID: 33401148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Chronic Bronchial Infection by
    García Clemente M; Olveira C; Girón R; Máiz L; Sibila O; Golpe R; Menéndez R; Rodríguez J; Barreiro E; Rodríguez Hermosa JL; Prados C; De la Rosa D; Carbajal CM; Solís M; Martínez-García MÁ
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of blood total immunoglobulin E and eosinophils with radiological features of bronchiectasis.
    Ren J; Chen A; Wang J; Chang C; Wang J; Sun L; Sun Y
    BMC Pulm Med; 2023 Aug; 23(1):316. PubMed ID: 37653511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary Immun Deficiency in Patients with Non-Cystic Fibrosis Bronchiectasis and Its Relationship with Clinical Parameters.
    Bekir M; Karakoç Aydıner E; Yıldızeli ŞO; Öğülür İ; Kocakaya D; Barış S; Eryüksel E; Özen A; Ceyhan BB
    Turk Thorac J; 2021 Jan; 22(1):37-44. PubMed ID: 33646102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Albumin and Disease Severity of Non-Cystic Fibrosis Bronchiectasis.
    Lee SJ; Kim HJ; Kim JY; Ju S; Lim S; Yoo JW; Nam SJ; Lee GD; Cho HS; Kim RB; Cho YJ; Jeong YY; Kim HC; Lee JD
    Respir Care; 2017 Aug; 62(8):1075-1084. PubMed ID: 28512120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T2 Biomarkers as Predictors of Exacerbations of Chronic Obstructive Pulmonary Disease.
    Alcázar-Navarrete B; Díaz-Lopez JM; García-Flores P; Ortega-Antelo M; Aguilar-Cruz I; Ruiz-Rodríguez O; Santiago-Diaz P; Romero Palacios PJ
    Arch Bronconeumol; 2022 Aug; 58(8):595-600. PubMed ID: 35312535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral Neutrophil-to-Lymphocyte Ratio in Bronchiectasis: A Marker of Disease Severity.
    Martinez-García MÁ; Olveira C; Girón R; García-Clemente M; Máiz-Carro L; Sibila O; Golpe R; Méndez R; Rodríguez Hermosa JL; Barreiro E; Prados C; Rodríguez López J; de la Rosa D
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Factors in Adult Patients with Non-Cystic Fibrosis Bronchiectasis.
    Machado BC; Jacques PS; Penteado LP; Roth Dalcin PT
    Lung; 2018 Dec; 196(6):691-697. PubMed ID: 30255201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.